Nitric oxide modulation of the immune response against cholera toxin-adjuvated ovalbumin administered by the intranasal route

Here, we studied the effect of aminoguanidine (AG) treatment, a nitric oxide synthase (NOS)-2 inhibitor, during the immune response against intranasal administration of ovalbumin (OVA) mixed with cholera toxin (CT) in BALB/c mice. NOS-2 mRNA was detected by reverse transcription-PCR (RT-PCR) in samp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 2004
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01652478_v92_n3_p245_Gamba
http://hdl.handle.net/20.500.12110/paper_01652478_v92_n3_p245_Gamba
Aporte de:
id paper:paper_01652478_v92_n3_p245_Gamba
record_format dspace
spelling paper:paper_01652478_v92_n3_p245_Gamba2023-06-08T15:14:52Z Nitric oxide modulation of the immune response against cholera toxin-adjuvated ovalbumin administered by the intranasal route Cholera toxin Mucosal immunity Nitric oxide aminoguanidine cholera toxin immunoglobulin A immunoglobulin G immunoglobulin G1 immunoglobulin G2a immunoglobulin M nitric oxide nitric oxide synthase inhibitor ovalbumin transforming growth factor beta analytic method animal cell antigen specificity article controlled study drug effect drug inhibition immune response inoculation male mouse mouse strain mucosal immunity nonhuman priority journal reverse transcription polymerase chain reaction sampling spleen cell Administration, Intranasal Animals Cholera Toxin Guanidines Immunity, Cellular Immunity, Mucosal Lung Mice Nitric Oxide Nitric Oxide Synthase Ovalbumin Transforming Growth Factor beta Turbinates Here, we studied the effect of aminoguanidine (AG) treatment, a nitric oxide synthase (NOS)-2 inhibitor, during the immune response against intranasal administration of ovalbumin (OVA) mixed with cholera toxin (CT) in BALB/c mice. NOS-2 mRNA was detected by reverse transcription-PCR (RT-PCR) in samples of lungs and turbinates early post-inoculation of the antigen. Animals intranasally treated with AG, showed an increase in the levels of seric specific IgG and IgM. A higher IgG1/IgG2a ratio against OVA was also observed in sera of same animals. Moreover, high levels of specific IgA were detected in samples of pulmonar washings obtained from treated animals. On the contrary, treated animals showed a lower DTH response while splenocytes obtained from the same animals showed a reduced proliferative capability against OVA compared to controls. Finally, RT-PCR analysis showed increased expression of TGF-β in turbinates, lungs and cells from pulmonar washings obtained from AG treated mice. Taken together, these data suggest a role of nitric oxide (NO) in modulating the primary immune response against intranasal antigens. © 2004 Published by Elsevier B.V. 2004 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01652478_v92_n3_p245_Gamba http://hdl.handle.net/20.500.12110/paper_01652478_v92_n3_p245_Gamba
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Cholera toxin
Mucosal immunity
Nitric oxide
aminoguanidine
cholera toxin
immunoglobulin A
immunoglobulin G
immunoglobulin G1
immunoglobulin G2a
immunoglobulin M
nitric oxide
nitric oxide synthase inhibitor
ovalbumin
transforming growth factor beta
analytic method
animal cell
antigen specificity
article
controlled study
drug effect
drug inhibition
immune response
inoculation
male
mouse
mouse strain
mucosal immunity
nonhuman
priority journal
reverse transcription polymerase chain reaction
sampling
spleen cell
Administration, Intranasal
Animals
Cholera Toxin
Guanidines
Immunity, Cellular
Immunity, Mucosal
Lung
Mice
Nitric Oxide
Nitric Oxide Synthase
Ovalbumin
Transforming Growth Factor beta
Turbinates
spellingShingle Cholera toxin
Mucosal immunity
Nitric oxide
aminoguanidine
cholera toxin
immunoglobulin A
immunoglobulin G
immunoglobulin G1
immunoglobulin G2a
immunoglobulin M
nitric oxide
nitric oxide synthase inhibitor
ovalbumin
transforming growth factor beta
analytic method
animal cell
antigen specificity
article
controlled study
drug effect
drug inhibition
immune response
inoculation
male
mouse
mouse strain
mucosal immunity
nonhuman
priority journal
reverse transcription polymerase chain reaction
sampling
spleen cell
Administration, Intranasal
Animals
Cholera Toxin
Guanidines
Immunity, Cellular
Immunity, Mucosal
Lung
Mice
Nitric Oxide
Nitric Oxide Synthase
Ovalbumin
Transforming Growth Factor beta
Turbinates
Nitric oxide modulation of the immune response against cholera toxin-adjuvated ovalbumin administered by the intranasal route
topic_facet Cholera toxin
Mucosal immunity
Nitric oxide
aminoguanidine
cholera toxin
immunoglobulin A
immunoglobulin G
immunoglobulin G1
immunoglobulin G2a
immunoglobulin M
nitric oxide
nitric oxide synthase inhibitor
ovalbumin
transforming growth factor beta
analytic method
animal cell
antigen specificity
article
controlled study
drug effect
drug inhibition
immune response
inoculation
male
mouse
mouse strain
mucosal immunity
nonhuman
priority journal
reverse transcription polymerase chain reaction
sampling
spleen cell
Administration, Intranasal
Animals
Cholera Toxin
Guanidines
Immunity, Cellular
Immunity, Mucosal
Lung
Mice
Nitric Oxide
Nitric Oxide Synthase
Ovalbumin
Transforming Growth Factor beta
Turbinates
description Here, we studied the effect of aminoguanidine (AG) treatment, a nitric oxide synthase (NOS)-2 inhibitor, during the immune response against intranasal administration of ovalbumin (OVA) mixed with cholera toxin (CT) in BALB/c mice. NOS-2 mRNA was detected by reverse transcription-PCR (RT-PCR) in samples of lungs and turbinates early post-inoculation of the antigen. Animals intranasally treated with AG, showed an increase in the levels of seric specific IgG and IgM. A higher IgG1/IgG2a ratio against OVA was also observed in sera of same animals. Moreover, high levels of specific IgA were detected in samples of pulmonar washings obtained from treated animals. On the contrary, treated animals showed a lower DTH response while splenocytes obtained from the same animals showed a reduced proliferative capability against OVA compared to controls. Finally, RT-PCR analysis showed increased expression of TGF-β in turbinates, lungs and cells from pulmonar washings obtained from AG treated mice. Taken together, these data suggest a role of nitric oxide (NO) in modulating the primary immune response against intranasal antigens. © 2004 Published by Elsevier B.V.
title Nitric oxide modulation of the immune response against cholera toxin-adjuvated ovalbumin administered by the intranasal route
title_short Nitric oxide modulation of the immune response against cholera toxin-adjuvated ovalbumin administered by the intranasal route
title_full Nitric oxide modulation of the immune response against cholera toxin-adjuvated ovalbumin administered by the intranasal route
title_fullStr Nitric oxide modulation of the immune response against cholera toxin-adjuvated ovalbumin administered by the intranasal route
title_full_unstemmed Nitric oxide modulation of the immune response against cholera toxin-adjuvated ovalbumin administered by the intranasal route
title_sort nitric oxide modulation of the immune response against cholera toxin-adjuvated ovalbumin administered by the intranasal route
publishDate 2004
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01652478_v92_n3_p245_Gamba
http://hdl.handle.net/20.500.12110/paper_01652478_v92_n3_p245_Gamba
_version_ 1768543555473637376